ARID1A and cancer: This suggests that hotspot mutations of TP53, LRP1B, and ARID1A, as potential cancer driver factors, occur earlier in the process of GCA initiation and are significantly enriched in cancer-related signaling pathways such as TP53, PTK-RAS, Wnt, and PI3K.